首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >Expression of Cell Cycle-associated Proteins p53, pRb, pi 6, p27, and Correlation With Survival: A Comparative Study on Oral Squamous Cell Carcinoma and Verrucous Carcinoma
【24h】

Expression of Cell Cycle-associated Proteins p53, pRb, pi 6, p27, and Correlation With Survival: A Comparative Study on Oral Squamous Cell Carcinoma and Verrucous Carcinoma

机译:细胞周期相关蛋白p53,pRb,pi 6,p27的表达及其与生存的关系:口腔鳞状细胞癌和疣状癌的比较研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract: Verrucous carcinoma (VC) is a well-differentiated form of squamous cell carcinoma (SCC) with better prognosis. Differences in molecular pathogenesis between the 2 have not been well-characterized. We conducted this study to evaluate im-munohistochemical expression of cell-cycle regulatory proteins p53, pRb, p16, and p27 in SCC and VC, compare the expression in these 2 neoplasms, and assess if these markers have any diagnostic or prognostic value. Sixty cases of SCC with and without lymph node metastasis and 31 cases of VC were studied. Immunohistochemical analysis for p53, pRb, pl6, and p27 was performed and the results were analyzed. SCC was most frequent in tongue (52%), whereas VC in buccal mucosa (81%). Mean age of SCC patients was significantly lower than in VC. Majority of SCCs were in stage III and IV (63%), whereas VCs were in stage I and II (84%). p53 im-munopositivity was more frequent in SCC (65%) than in VC (23%) (P< 0.001). VC had lower p53 as compared with well-differentiated SCC and SCC without lymph node metastasis. No significant difference was seen in pRb, p16, and p27 expression. Disease-free survival (DFS) at 1 year for SCC was 57% whereas it was 80% for VC (P = 0.02). DFS and overall survival of SCC correlated with nodal status and stage; cell-cycle-associated protein expression had no association with DFS. To conclude, p53 im-munoexpression differs in SCC and VC, suggesting different pathogenesis, and it may have some utility as an adjunct to morphology to differentiate between the 2. Expression of cell-cycle-associated proteins does not influence survival in SCC.
机译:摘要:疣状癌(VC)是一种分化良好的鳞状细胞癌(SCC),预后较好。两者之间在分子发病机理上的差异尚未得到很好的表征。我们进行了这项研究,以评估SCC和VC中细胞周期调节蛋白p53,pRb,p16和p27的免疫组织化学表达,比较这两种肿瘤中的表达,并评估这些标志物是否具有诊断或预后价值。研究了60例伴和不伴淋巴结转移的SCC和31例VC。对p53,pRb,p16和p27进行了免疫组织化学分析,并对结果进行了分析。舌癌最常见(52%),颊黏膜VC(81%)。 SCC患者的平均年龄显着低于VC。 SCC的大多数处于第三和第四阶段(63%),而VC处于第一和第二阶段(84%)。 SCC(65%)的p53免疫阳性率比VC(23%)更高(P <0.001)。与分化良好的SCC和无淋巴结转移的SCC相比,VC的p53较低。在pRb,p16和p27表达中未见明显差异。 SCC 1年无病生存率(DFS)为57%,而VC为80%(P = 0.02)。 DFS和SCC的总生存率与淋巴结状态和分期有关;细胞周期相关蛋白表达与DFS无关。总而言之,p53免疫表达在SCC和VC中有所不同,提示发病机理不同,并且它可能作为形态学的辅助物来区分2。细胞周期相关蛋白的表达不影响SCC的存活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号